ZOLL Medical Corporation  

• Home
• Products
• Additional Info

LifeVest

With 20+ years of clinical evidence and real-world use across more than one million patients, the LifeVest wearable cardioverter defibrillator (WCD) is the trusted solution to provide protection for patients at risk of sudden cardiac death.... More Info Less Info







The LifeVest® wearable cardioverter defibrillator (WCD) is a treatment option for patients at risk of sudden cardiac death (SCD). LifeVest is designed to continuously monitor a patient’s heart, detect certain life-threatening rapid heart rhythms, and automatically deliver a treatment shock to restore normal heart rhythm. In a typical situation, the entire event, from detecting a life-threatening rapid heart rhythm to automatically delivering a shock, occurs in about one minute.

Over more than two decades, LifeVest has provided protection to hundreds of thousands of patients and saved thousands of lives. The safe and effective use of LifeVest has been demonstrated in extensive clinical research. 



WatchPAT ONE Home Sleep Apnea Test

Sleep apnea is associated with adverse outcomes for cardiac patients. WatchPAT ONE is simple to operate, with fast and accurate results, and has been proven to deliver similar results to in-lab testing. Simplify the diagnosis of comorbid sleep apnea.... More Info Less Info





Sleep apnea is associated with adverse outcomes for cardiac patients. WatchPAT ONE is simple to operate, with fast and accurate results, and has been proven to deliver similar results to in-lab testing. Simplify the diagnosis of comorbid sleep apnea.



HFMS

HFMS is a non-invasive, patch-based device that uses novel radiofrequency technology for early detection of changes in pulmonary fluid levels, an increase in which is an early indicator of heart failure decompensation.... More Info Less Info





ZOLL HFMS is a non-invasive, patch-based device that uses novel radiofrequency technology for early detection of changes in pulmonary fluid levels, an increase in which is an early indicator of heart failure decompensation.

• Radar waves can be used to measure interstitial edema, an early sign of heart failure
• Changes in signal path delay and strength indicate changes in fluid
• Waves are highly modulated by tissue hydration, producing a very sensitive, robust measurement known as Thoracic Fluid Index (TFI)

ZOLL HFMS also records, stores, and transmits additional patient data that can be used to inform care plans, including heart rate, respiration rate, activity, posture, and heart rhythm (ECG).

We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!

ACC.24 Learning Pathways? (select all that apply)

First time Exhibitor?